Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$978K Hold
7,609
0.13% 77
2026
Q1
$915K Buy
7,609
+1,531
+25% +$177K 0.15% 70
2025
Q4
$640K Sell
6,078
-505
-8% -$47.4K 0.11% 81
2025
Q3
$552K Hold
6,583
0.09% 86
2025
Q2
$521K Buy
6,583
+115
+2% +$9.14K 0.09% 88
2025
Q1
$581K Buy
6,468
+61
+1% +$5.7K 0.11% 78
2024
Q4
$637K Sell
6,407
-301
-4% -$31K 0.13% 73
2024
Q3
$762K Buy
6,708
+157
+2% +$18.7K 0.16% 59
2024
Q2
$811K Hold
6,551
0.19% 53
2024
Q1
$864K Hold
6,551
0.22% 49
2023
Q4
$714K Buy
6,551
+91
+1% +$9.45K 0.21% 54
2023
Q3
$665K Hold
6,460
0.24% 49
2023
Q2
$745K Buy
6,460
+123
+2% +$14K 0.26% 44
2023
Q1
$674K Hold
6,337
0.27% 46
2022
Q4
$703K Sell
6,337
-105
-2% -$10.7K 0.31% 43
2022
Q3
$555K Buy
6,442
+186
+3% +$16.6K 0.28% 49
2022
Q2
$570K Sell
6,256
-821
-12% -$72.8K 0.29% 50
2022
Q1
$581K Buy
7,077
+32
+0.5% +$2.52K 0.26% 57
2021
Q4
$540K Buy
7,045
+130
+2% +$10.4K 0.23% 64
2021
Q3
$519K Buy
6,915
+30
+0.4% +$2.28K 0.24% 59
2021
Q2
$535K Sell
6,885
-1,170
-15% -$87K 0.25% 53
2021
Q1
$592K Buy
8,055
+560
+7% +$41.3K 0.32% 47
2020
Q4
$585K Sell
7,495
-869
-10% -$66.5K 0.36% 41
2020
Q3
$663K Buy
8,364
+38
+0.5% +$2.98K 0.47% 28
2020
Q2
$614K Hold
8,326
0.49% 27
2020
Q1
$611K Buy
8,326
+4,937
+146% +$388K 0.6% 24
2019
Q4
$294K Buy
3,389
+308
+10% +$25.3K 0.24% 47
2019
Q3
$247K Buy
+3,081
New +$247K 0.23% 53

Other funds holding MRK

IFG Advisors's MRK Position: Q2 2026 in Review

IFG Advisors held its Merck (MRK) position steady in Q2 2026 at 7,609 shares worth $978K. The position accounts for 0.13% of the portfolio, ranked #77.

IFG Advisors first reported a position in MRK in Q3 2019 and has held it in 28 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • IFG Advisors held 7,609 shares of Merck worth $978K as of Q2 2026.
  • IFG Advisors left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.13% of IFG Advisors's portfolio in Q2 2026, its #77 holding.
  • IFG Advisors first reported a position in Merck in Q3 2019 and has held it in 28 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on IFG Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.